MedTrace Logo

Intravenous Immunoglobin Transfusion in Preterm Infants With Encephalopathy of Prematurity

NCT02822027 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-10-14

No results posted yet for this study

Summary

Infection and inflammation is related to increased encephalopathy of prematurities.

Conditions

  • Preterm Infants

Interventions

DRUG

human gamma globulin

human gamma globulin for preterm infants with encephalopathy of prematurities

DRUG

non-human gamma globulin

Non-human gamma globulin for preterm infants with encephalopathy of prematurities

Sponsors & Collaborators

  • Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
6 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2024-12-01
Completion
2024-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02822027 on ClinicalTrials.gov